Search

You searched for "correction"

2931 results found

“I can see fine. Why do I need my eyes tested?”

2 December 2019 | | EYE - General
Are routine eye examinations really necessary? The author asks whether frequent appointments in low-risk patients with normal results are actually cost-effective. It’s recommended that most people should get their eyes tested every two years.” [1] This message is widely publicised...

International Ocular Inflammation Society (IOIS) Congress September 2023 in a sweltering Berlin

14 September 2023 | | IOIS, Berlin, Conference, Report, Event, ocular inflammation, Hagar Ibrahim, Dhanach Dhirachaikulpanich, Nima Ghadiri
Approaching its 40th year, IOIS remains focused on advancing research and knowledge-sharing around ocular inflammatory diseases.

Surgical treatment for monocular elevation deficit

2 December 2019 | | EYE - Paediatrics, EYE - Strabismus
Type 1 monocular elevation deficiency is a restrictive form identified by positive results on forced duction testing in elevation, normal elevation forced generation test, elevation of saccadic velocity and absence of poor Bell’s phenomenon. The authors aimed to evaluate the...

Intravitreal dexamethasone implant for diabetic macular oedema

1 February 2015 | | EYE - Paediatrics, EYE - Strabismus
The authors report on the three-year outcomes of the Ozurdex Dexamethasone (DEX) intravitreal implant multi-centre trial for the treatment of diabetic macular oedema (DME). Patients with DME (best-corrected vision of 20/50 to 20/200 and central retinal thickness of ≥300µm) were...

Injection of methotrexate into silicone oil-filled eyes for grade C PVR

1 October 2019 | | EYE - Vitreo-Retinal
Methotrexate (MTX) is an antineoplastic antimetabolite with immunosuppressant properties. Folate antagonism is known to contribute to the antiproliferative effects of MTX, and release of adenosine from cells and inhibition of polyamines may explain its anti-inflammatory effects. These activities contribute to...

RCSED Basic Microsurgical Skills Course

27 April 2026
The Royal College of Surgeons of Edinburgh Basic Microsurgical Skills Course

Preventing blindness from diabetes: planning a programme of service development and research across Malawi

5 April 2022 | | EYE - Vitreo-Retinal, EYE - Imaging, EYE - General
In sub-Saharan Africa 19.4 million people have diabetes; this is projected to rise to 28.6 million by 2030 [1]. Sight loss from diabetes devastates the lives of working people, affecting the financial stability of the families and communities who depend...

Lord Trees and Baroness Sugg call to end Neglected Tropical Diseases with charity coalition at Westminster event

9 June 2022
UK Coalition against Neglected Tropical Diseases works alongside co-host parliamentary reception in the House of Lords.

Effect of minor trauma in eyes with previously undiagnosed angioid streaks

1 April 2014 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Angioid streaks (AS) may be associated with pseudoxanthoma elasticum (PXE), Paget’s disease, haemoglobulinopathies, Ehlers-Danlos Syndrome or abetalipoproteinaemia. Histopathology showed retinal pigment epithelium (RPE) and choriocapillaris loss, elastic fibre degeneration, calcium deposition, active choroidal neovascular membrane (CNVM) and vascular endothelial growth...

AI predicts eye damage from autoimmune drug, years before symptoms appear

1 September 2025 | artificial intelligence, hydroxychloroquine, pharmacology, research, Moorfields
A novel AI tool could transform screening for patients taking hydroxychloroquine by spotting early signs of eye damage, according to a study published in Opthalmology Retina. Researchers have devised an artificial intelligence (AI) system that can detect and predict serious...

Fight for Sight to maximise impact by funding solutions-focused research in priority eye conditions

1 August 2018 | | EYE - General
Fight for Sight aims to stop sight loss by funding pioneering research. Rod McNeil takes a look at the Primer Fellowship Awards programme, which provides funding for up to £60,000 for individuals to undertake vision-related research for one year. Among...

Capacity-strengthening for diabetic retinopathy services in low- and middle-income countries

3 February 2023 | | EYE - General
Introduction DR-NET eye health professionals in low- and middle-income countries (LMICs) have, since 2015, been able to access training in diabetic retinopathy (DR) grading provided by Gloucestershire Retinal Education Group (GREG). GREG, led by Professor Peter Scanlon and based at...